Intensity-modulated radiation therapy in oropharyngeal carcinoma: Effect of tumor volume on clinical outcomes

International Journal of Radiation Oncology Biology Physics

Volumn 82, Issue 5, 2012, Pages 1851-1857

  Lok, Benjamin H ^a,b   Setton, Jeremy ^a   Caria, Nicola ^a   Romanyshyn, Jonathan ^a   Wolden, Suzanne L ^a   Zelefsky, Michael J ^a   Park, Jeffery ^a   Rowan, Nicholas ^a   Sherman, Eric J ^a   Fury, Matthew G ^a   Ho, Alan ^a   Pfister, David G ^a   Wong, Richard J ^a   Shah, Jatin P ^a   Kraus, Dennis H ^a   Zhang, Zhigang ^a   Schupak, Karen D ^a   Gelblum, Daphna Y ^a   Rao, Shyam D ^a   Lee, Nancy Y ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Clinical outcomes; Head and neck cancer; IMRT; Oropharyngeal cancer; Tumor volume

Indexed keywords

CLINICAL OUTCOME; HEAD-AND-NECK CANCER; IMRT; OROPHARYNGEAL CANCER; TUMOR VOLUME;

DISEASES; PATIENT MONITORING; PHYSICAL THERAPY; RISK ANALYSIS; TUMORS;

PATIENT TREATMENT;

ANTINEOPLASTIC AGENT; BEVACIZUMAB; CARBOPLATIN; CETUXIMAB; CISPLATIN; FLUOROURACIL;

ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER CONTROL; CANCER MORTALITY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURVIVAL; COHORT ANALYSIS; DISEASE SEVERITY; DISTANT METASTASIS; FEMALE; FOLLOW UP; GROSS TUMOR VOLUME; HUMAN; INCIDENCE; INTENSITY MODULATED RADIATION THERAPY; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; OROPHARYNX CARCINOMA; OUTCOME ASSESSMENT; OVERALL SURVIVAL; POSTOPERATIVE CARE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE; SURVIVAL TIME; TREATMENT FAILURE; TREATMENT PLANNING; TUMOR VOLUME;

ANALYSIS OF VARIANCE; ANTINEOPLASTIC AGENTS; CARCINOMA, SQUAMOUS CELL; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPHATIC METASTASIS; MALE; OROPHARYNGEAL NEOPLASMS; PROPORTIONAL HAZARDS MODELS; RADIOTHERAPY, INTENSITY-MODULATED; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME; TUMOR BURDEN;

EID: 84858702212     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2011.03.029     Document Type: Article

References (25)

1. Sobin LH, Gospodarowicz MK, Wittekind C, International Union Against Cancer. TNM classification of malignant tumours. 7th ed. Hoboken, NJ: Wiley-Blackwell; 2010.
2. American Joint Committee on Cancer. AJCC cancer staging manual. New York: Springer; 2009.
3. Kraas JR, Underhill TE, D'Agostino RB Jr., et al. Quantitative analysis from CT is prognostic for local control of supraglottic carcinoma. Head Neck 2001;23:1031-1036. (Pubitemid 33107932)
4. Mendenhall WM, Morris CG, Amdur RJ, et al. Parameters that predict local control after definitive radiotherapy for squamous cell carcinoma of the head and neck. Head Neck 2003;25:535-542. (Pubitemid 36736872)
5. Hermans R, Van den Bogaert W, Rijnders A, et al. Predicting the local outcome of glottic squamous cell carcinoma after definitive radiation therapy: Value of computed tomographydetermined tumour parameters. Radiother Oncol 1999;50: 39-46. (Pubitemid 29136737)
6. Chen SW, Yang SN, Liang JA, Tsai MH, Shiau AC, Lin FJ. Value of computed tomography-based tumor volume as a predictor of outcomes in hypopharyngeal cancer after treatment with definitive radiotherapy. Laryngoscope 2006; 116:2012-2017.
7. Chua DT, Sham JS, Kwong DL, et al. Volumetric analysis of tumor extent in nasopharyngeal carcinoma and correlation with treatment outcome. Int J Radiat Oncol Biol Phys 1997; 39:711-719. (Pubitemid 27441441)
8. Pameijer FA, Mancuso AA, Mendenhall WM, et al. Evaluation of pretreatment computed tomography as a predictor of local control in T1/T2 pyriform sinus carcinoma treated with definitive radiotherapy. Head Neck 1998;20:159-168. (Pubitemid 28106229)
9. Le Tourneau C, Velten M, Jung GM, et al. Prognostic indicators for survival in head and neck squamous cell carcinomas: Analysis of a series of 621 cases. Head Neck 2005;27:801-808. (Pubitemid 41266184)
10. Keberle M, Hoppe F, Dotzel S, Hahn D. [Prognostic value of pretreatment CT regarding local control in oropharyngeal cancer after primary surgical resection] (in German). Fortschr Röntgenstr 2003;175:61-66.
11. Nathu RM, Mancuso AA, Zhu TC, Mendenhall WM. The impact of primary tumor volume on local control for oropharyngeal squamous cell carcinoma treated with radiotherapy. Head Neck 2000;22:1-5. (Pubitemid 30030662)
12. Been MJ,Watkins J, Manz RM, et al. Tumor volume as a prognostic factor in oropharyngeal squamous cell carcinoma treated with primary radiotherapy. Laryngoscope 2008;118:1377-1382.
13. Hermans R, Op de Beeck K, Van den Bogaert W, et al. The relation of CT-determined tumor parameters and local and regional outcome of tonsillar cancer after definitive radiation treatment. Int J Radiat Oncol Biol Phys 2001;50:37-45.
14. Chao KS, Ozyigit G, Blanco AI, et al. Intensity-modulated radiation therapy for oropharyngeal carcinoma: Impact of tumor volume. Int J Radiat Oncol Biol Phys 2004;59:43-50. (Pubitemid 38501505)
15. Studer G, Lutolf UM, El-Bassiouni M, Rousson V, Glanzmann C. Volumetric staging (VS) is superior to TNM and AJCC staging in predicting outcome of head and neck cancer treated with IMRT. Acta Oncol 2007;46:386-394. (Pubitemid 46625041)
16. de Arruda FF, Puri DR, Zhung J, et al. Intensity-modulated radiation therapy for the treatment of oropharyngeal carcinoma: The Memorial Sloan-Kettering Cancer Center experience. Int J Radiat Oncol Biol Phys 2006;64:363-373. (Pubitemid 43083420)
17. Lee N, Mechalakos J, Puri DR, Hunt M. Choosing an intensitymodulated radiation therapy technique in the treatment of head-and-neck cancer. Int J Radiat Oncol Biol Phys 2007;68: 1299-1309. (Pubitemid 47176788)
18. Fleming I, for the American Joint Committee on Cancer, National Cancer Institute (U.S.). AJCC cancer staging manual. 5th ed. Philadelphia: Lippincott-Raven; 1997.
19. Blomberg M, Nielsen A, Munk C, Kjaer SK. Trends in head and neck cancer incidence in Denmark, 1978-2007: Focus onhuman papillomavirus associated sites. Int J Cancer 2011;129:n/a.
20. Ang KK, Harris J, Wheeler R, et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med 2010;363:24-35.
21. Al-Swiahb JN, Huang CC, Fang FM, et al. Prognostic impact of p16, p53, epidermal growth factor receptor, and human papillomavirus in oropharyngeal cancer in a betel nut-chewing area. Arch Otolaryngol Head Neck Surg 2010;136:502-508.
22. Nichols AC, Finkelstein DM, Faquin WC, et al. Bcl2 and human papilloma virus 16 as predictors of outcome following concurrent chemoradiation for advanced oropharyngeal cancer. Clin Cancer Res 2010;16:2138-2146.
23. Rischin D, Young RJ, Fisher R, et al. Prognostic significance of p16INK4A and human papillomavirus in patients with oropharyngeal cancer treated on TROG 02.02 phase III trial. J Clin Oncol 2010;28:4142-4148.
24. Mellin H, Friesland S, Lewensohn R, et al. Human papillomavirus (HPV) DNA in tonsillar cancer: Clinical correlates, risk of relapse, and survival. Int J Cancer 2000;89:300-304. (Pubitemid 30430748)
25. Sedaghat AR, Zhang Z, Begum S, et al. Prognostic significance of human papillomavirus in oropharyngeal squamous cell carcinomas. Laryngoscope 2009;119:1542-1549.